2018

Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells

Kirkling ME, Cytlak U, Lau CM, Lewis KL, Resteu A, Khodadadi-Jamayran A, Siebel CW, Salmon H, Merad M, Tsirigos A, Collin M, Bigley V, Reizis B.

Show affiliations
  • Kirkling MEDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA; Graduate Program in Genetics and Development, Columbia University Medical Center, New York, NY 10032, USA.
  • Cytlak UInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Lau CMDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA.
  • Lewis KLDepartment of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA.
  • Resteu AInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
  • Khodadadi-Jamayran ADepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA; Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.
  • Siebel CWGenentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Salmon HDepartment of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY 10028, USA.
  • Merad MDepartment of Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY 10028, USA.
  • Tsirigos ADepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA; Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.
  • Collin MInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Road, Newcastle upon Tyne NE7 7DN, UK.
  • Bigley VInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Road, Newcastle upon Tyne NE7 7DN, UK. Electronic address: venetia.bigley@newcastle.ac.uk.
  • Reizis BDepartment of Pathology, New York University School of Medicine, New York, NY 10016, USA; Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: boris.reizis@nyumc.org.
1 read0 want to read

The IRF8-dependent subset of classical dendritic cells (cDCs), termed cDC1, is important for cross-priming cytotoxic T cell responses against pathogens and tumors. Culture of hematopoietic progenitors with DC growth factor FLT3 ligand (FLT3L) yields very few cDC1s (in humans) or only immature "cDC1-like" cells (in the mouse). We report that OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1) optimize FLT3L-driven development of cDC1s from murine immortalized progenitors and primary bone marrow cells. Co-culture with OP9-DL1 induced IRF8-dependent cDC1s with a phenotype (CD103+ Dec205+ CD8α+) and expression profile resembling primary splenic cDC1s. OP9-DL1-induced cDC1s showed preferential migration toward CCR7 ligands in vitro and superior T cell cross-priming and antitumor vaccination in vivo. Co-culture with OP9-DL1 also greatly increased the yield of IRF8-dependent CD141+ cDC1s from human bone marrow progenitors cultured with FLT3L. Thus, Notch signaling optimizes cDC generation in vitro and yields authentic cDC1s for functional studies and translational applications.

Most-cited papers citing this

  • Signal Transduct Target Ther · 2022 · cited by 845
  • J Hematol Oncol · 2023 · cited by 114
  • Sci Immunol · 2024 · cited by 79
  • Nat Immunol · 2023 · cited by 78
  • Nat Immunol · 2024 · cited by 73

Log in to like, log, and share thoughts on this paper.

Discussion

Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.

No discussion yet — be the first to share constructive thoughts.